dostęp otwarty

Tom 3, Nr 3 (2017)
Prace oryginalne
Opublikowany online: 2017-10-24
Pobierz cytowanie

Ocena morfologii i dystrybucji naczyń włosowatych w kapilaroskopii wału paznokciowego u chorych na twardzinę układową i zdrowych osób

Zofia Gerlicz-Kowalczuk, Katarzyna Płużańska-Srebrzyńska, Elżbieta Dziankowska-Zaborszczyk, Bożena Dziankowska-Bartkowiak
Forum Dermatologicum 2017;3(3):71-74.

dostęp otwarty

Tom 3, Nr 3 (2017)
Prace oryginalne
Opublikowany online: 2017-10-24

Streszczenie

Introduction: Systemic sclerosis (SSc) is a connective tissue disease characterized by vascular damage and immunological abnormalities leading to fibrosis that can damage multiple organs. The pathogenesis is complex and still poorly understood. However impaired angiogenesis in SSc has a major role in tissue injury and sequelae fibrosis. Nailfold capillaroscopy (NC)/nailfold videocapillaroscopy (NVC) is safe and non-invasive methods used to investigate microvascular changes in the peripheral circulation and it is a method of great diagnostic value in diagnosing and monitoring the patients with SSc. Typical microvascular alterations, called scleroderma pattern characterized by giant capillaries, haemorrhages and successive loss of capillaries, are observed at NC/NVC in a significant percentage of SSc patients, hence our interest was focused on the assessment of NVC in patient with systemic sclerosis (SSc).

Material and methods: Thirty patients with SSc according to the ACR and EULAR criteria and healthy volunteers underwent NVC assessment. Nailfold capillaroscopy was performed by a videocapillaroscope and the picture of the capillaries at the hands were documented and evaluate. Results: NVC disturbed patterns were significantly prominent in SSc patients (p < 0.05) compared to the healthy control group. A normal capillaroscopic pattern was not observed in patients with SSc. The number of loops/mm was significantly lower in SSc group (p < 0.05) and was 4.28 capillaries/mm (min.1/mm; max. 10/mm). We did not notice significant difference in frequency of mega-capillaries (lcSSc/dcSSc: 41%/29%, p > 0.05) and avascular areas (lcSSc/dcSSc: 64%/57%, p > 0.05) between limited (lSSc) and diffuse (dSSc) SSc.

Conclusions: Severe capillary damage is characteristic for SSc patients therefore NVC seems to be useful for selection of patients developing SSc.

Streszczenie

Introduction: Systemic sclerosis (SSc) is a connective tissue disease characterized by vascular damage and immunological abnormalities leading to fibrosis that can damage multiple organs. The pathogenesis is complex and still poorly understood. However impaired angiogenesis in SSc has a major role in tissue injury and sequelae fibrosis. Nailfold capillaroscopy (NC)/nailfold videocapillaroscopy (NVC) is safe and non-invasive methods used to investigate microvascular changes in the peripheral circulation and it is a method of great diagnostic value in diagnosing and monitoring the patients with SSc. Typical microvascular alterations, called scleroderma pattern characterized by giant capillaries, haemorrhages and successive loss of capillaries, are observed at NC/NVC in a significant percentage of SSc patients, hence our interest was focused on the assessment of NVC in patient with systemic sclerosis (SSc).

Material and methods: Thirty patients with SSc according to the ACR and EULAR criteria and healthy volunteers underwent NVC assessment. Nailfold capillaroscopy was performed by a videocapillaroscope and the picture of the capillaries at the hands were documented and evaluate. Results: NVC disturbed patterns were significantly prominent in SSc patients (p < 0.05) compared to the healthy control group. A normal capillaroscopic pattern was not observed in patients with SSc. The number of loops/mm was significantly lower in SSc group (p < 0.05) and was 4.28 capillaries/mm (min.1/mm; max. 10/mm). We did not notice significant difference in frequency of mega-capillaries (lcSSc/dcSSc: 41%/29%, p > 0.05) and avascular areas (lcSSc/dcSSc: 64%/57%, p > 0.05) between limited (lSSc) and diffuse (dSSc) SSc.

Conclusions: Severe capillary damage is characteristic for SSc patients therefore NVC seems to be useful for selection of patients developing SSc.

Pobierz cytowanie

Słowa kluczowe

systemic sclerosis, nailfold capillaroscopy, connective tissue disease

Informacje o artykule
Tytuł

Ocena morfologii i dystrybucji naczyń włosowatych w kapilaroskopii wału paznokciowego u chorych na twardzinę układową i zdrowych osób

Czasopismo

Forum Dermatologicum

Numer

Tom 3, Nr 3 (2017)

Strony

71-74

Data publikacji on-line

2017-10-24

Rekord bibliograficzny

Forum Dermatologicum 2017;3(3):71-74.

Słowa kluczowe

systemic sclerosis
nailfold capillaroscopy
connective tissue disease

Autorzy

Zofia Gerlicz-Kowalczuk
Katarzyna Płużańska-Srebrzyńska
Elżbieta Dziankowska-Zaborszczyk
Bożena Dziankowska-Bartkowiak

Referencje (16)
  1. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988; 15(2): 202–205.
  2. Masy AT, Rodnan GP, Medsger TA, et al. Diagnostic and Therapeutic Criteria Committee Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980; 23: 581–90.
  3. LeRoy EC, Medsger TA. Criteria for the classification of early systemic sclerosis. J Rheumatol. 2001; 28(7): 1573–1576.
  4. Matucci-Cerinic M, Allanore Y, Czirják L, et al. The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy. Ann Rheum Dis. 2009; 68(9): 1377–1380.
  5. Cutolo M, Sulli A, Smith V. Assessing microvascular changes in systemic sclerosis diagnosis and management. Nat Rev Rheumatol. 2010; 6(10): 578–587.
  6. Lambova SN, Müller-Ladner U. Capillaroscopic pattern in systemic sclerosis - an association with dynamics of processes of angio- and vasculogenesis. Microvasc Res. 2010; 80(3): 534–539.
  7. van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013; 72(11): 1747–1755.
  8. Michalska-Jakubus M, Chodorowska G, Krasowska D. Kapilaroskopia wału paznokciowego. Mikroskopowa ocena zmian morfologicznych mikrokrążenia w twardzinie układowej. Post Dermatol Alergol. 2010; 27: 106–118.
  9. Ghizzoni C, Sebastiani M, Manfredi A, et al. Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications. Microvasc Res. 2015; 99: 92–95.
  10. Cutolo M, Pizzorni C, Sulli A, et al. Early Diagnostic and Predictive Value of Capillaroscopy in Systemic Sclerosis. Current Rheumatology Reviews. 2014; 9(4): 249–253.
  11. Bhakuni DS, Vasdev V, Garg MK, et al. Nailfold capillaroscopy by digital microscope in an Indian population with systemic sclerosis. Int J Rheum Dis. 2012; 15(1): 95–101.
  12. Rossi D, Russo A, Manna E, et al. The role of nail-videocapillaroscopy in early diagnosis of scleroderma. Autoimmun Rev. 2013; 12(8): 821–825.
  13. Lovy M, MacCarter D, Steigerwald JC. Relationship between nailfold capillary abnormalities and organ involvement in systemic sclerosis. Arthritis Rheum. 1985; 28(5): 496–501.
  14. Riccieri V, Vasile M, Iannace N, et al. Systemic sclerosis patients with and without pulmonary arterial hypertension: a nailfold capillaroscopy study. Rheumatology (Oxford). 2013; 52(8): 1525–1528.
  15. Smith V, Riccieri V, Pizzorni C, et al. Nailfold capillaroscopy for prediction of novel future severe organ involvement in systemic sclerosis. J Rheumatol. 2013; 40(12): 2023–2028.
  16. Sato LT, Kayser C, Andrade LEC. Nailfold capillaroscopy abnormalities correlate with cutaneous and visceral involvement in systemic sclerosis patients. Acta Reumatol Port. 2009; 34(2A): 219–227.

Ważne: serwis https://journals.viamedica.pl/ wykorzystuje pliki cookies. Więcej >>

Używamy informacji zapisanych za pomocą plików cookies m.in. w celach statystycznych, dostosowania serwisu do potrzeb użytkownika (np. język interfejsu) i do obsługi logowania użytkowników. W ustawieniach przeglądarki internetowej można zmienić opcje dotyczące cookies. Korzystanie z serwisu bez zmiany ustawień dotyczących cookies oznacza, że będą one zapisane w pamięci komputera. Więcej informacji można znaleźć w naszej Polityce prywatności.

Czym są i do czego służą pliki cookie możesz dowiedzieć się na stronie wszystkoociasteczkach.pl.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl